Lieu EL, Nguyen T, Rhyne S, Kim J
Preclinical findings suggest protective effects, but clinical evidence remains limited
En un ensayo internacional con ms de 17,600 personas con exceso de peso, las inyecciones semanales de Wegovy redujeron significativamente el riesgo de un episodio cardiaco grave
Related Reading Direct Meds Legit Henry Meds Glp 1 Orderly Meds Legit Henry Meds Tirzepatide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
However, its relationship with blood coagulation is complex and warrants a deeper exploration